Related Experiment Video

Updated: Jun 13, 2026

Routine Screening Method for Microparticles in Platelet Transfusions
09:49

Routine Screening Method for Microparticles in Platelet Transfusions

Published on: January 31, 2018

[Guideline for diagnosis and treatment of immune thrombocytopenia]

    Archivos Argentinos De Pediatria
    |May 15, 2010
    PubMed

    Insights

    Management of immune thrombocytopenia (ITP) remains controversial, lacking global consensus. This guideline clarifies diagnostic criteria, prognosis, and treatments for acute and chronic ITP, including bleeding management.

    Area of Science:

    • Hematology
    • Immunology
    • Internal Medicine

    Context:

    • Immune thrombocytopenia (ITP) management is debated, with multiple expert guidelines but no universal agreement.
    • Existing guidelines offer differing opinions, highlighting the need for a consolidated approach.

    Purpose:

    • To establish clear diagnostic criteria for ITP.
    • To outline initial laboratory investigations and differential diagnoses.
    • To provide a comprehensive overview of ITP prognosis, outcomes, and treatment options for acute and chronic forms, including emergency management of severe bleeding.

    Summary:

    • This guideline addresses the controversies in immune thrombocytopenia (ITP) by defining diagnostic standards and initial tests.
    • It details differential diagnoses, prognosis, and treatment strategies for both acute and chronic ITP.
    • Specific guidance is provided for managing life-threatening bleeding complications associated with ITP.

    Impact:

    • Aims to standardize ITP diagnosis and management globally.
    • Provides clinicians with evidence-based recommendations for patient care.
    • Facilitates improved outcomes for patients with immune thrombocytopenia.

    Related Concept Videos

    Venous Thrombosis III: Interprofessional Care01:29

    Venous Thrombosis III: Interprofessional Care

    Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
    Venous Thrombosis IV: Nursing Management01:30

    Venous Thrombosis IV: Nursing Management

    Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
    Disorders of Hemostasis01:24

    Disorders of Hemostasis

    Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
    Thromboembolic Disorders
    Two factors primarily cause thromboembolic conditions.
    Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

    Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

    Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...